61.36 0.00 (0.00%)
After hours: 4:56PM EDT
|Bid||61.03 x 800|
|Ask||61.39 x 800|
|Day's range||61.33 - 63.00|
|52-week range||56.58 - 72.81|
|Beta (3Y monthly)||0.80|
|PE ratio (TTM)||19.45|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Patterson Companies (PDCO) continues to benefit from robust product portfolio, strong prospects in Animal Health unit and strategic buyouts. However, intense competition remains a woe.
Paylocity, Macy's, Henry Schein, DENTSPLY and Patterson Companies highlighted as Zacks Bull and Bear of the Day
Henry Schein (HSIC) delivered earnings and revenue surprises of 1.20% and -1.26%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Investing.com - Henry Schein reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that fell short of forecasts.
Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
GW Pharmaceuticals (GWPH) is witnessing a solid new patient recruitment for Epidolex and a huge number of physicians are recommending the same in their prescriptions.
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Better-than-expected performance at Technology & Equipment and growth in emerging markets are likely to aid DENTSPLY SIRONA (XRAY) in Q2 earnings.
Better-than-expected performance at Pharmaceutical Distribution and higher revenues are likely to aid AmerisourceBergen (ABC) in Q3 earnings.
Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.